• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/33

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

33 Cards in this Set

  • Front
  • Back
Effect of Stimulation of cholinergic receptors-M3
bronchoconstriction
M3 Receptors location
bronchial smooth muscle
β2 Receptors location
airways
Action of inflammatory mediators on bronchial smooth muscle-
bronchoconstriction
How is inflammation in bronchial asthma managed
Corticosteroids
Mast cell stabilizers
How is bronchoconstriction managed
β2 Receptor Agonists
Muscarinic Receptor Antagonist
Xanthine derivatives.
Leucotriene Receptor Antagonist
Aerosol delivery of drugs(4)
High local concentration of drug
Low systemic delivery of drugs
Significantly less side effects
Spacer device improves the ratio of inhaled to swallowed drug, No hand mouth coordination needed.
Short Acting beta2 agonist
Salbutamol
Albuterol
Terbutaline
Metaproterenol

MAST
Long acting B2 agonist
Salmeterol
Formeterol
ADR β2 Agonists (5)
Fine tremors (of the fingers of the hand)
Palpitations
Dizziness
Restlessness
Agitation

FDRAP
Can Glucocorticoids be used for the treatment of acute bronchoconstriction
Glucocorticoids do not relax the bronchial smooth muscle and have no role in the treatment of acute bronchoconstriction
MOA Glucocorticoids
Modulation of cytokine and chemokine production
Inhibition of eicosanoid synthesis,
Inhibition of accumulation of mast cells
Decrease in vascular permeability
ADR of Glucocorticoids
minimal
Dysphonia (voice issues)
Oral candidiasis
How can the ADR of Glucocorticoids be prevented
advising the Pts to gargle the mouth with saline water
Leukotriene Receptor Blockers
Montelukast
Zafirlukast
Leukotriene Synthesis Inhibitors
Zileuton
MOA of Leukotriene Modulators
They act by antagonizing the actions of Leukotrienes
Inhibit bronchoconstriction
Decrease microvascular leakage and mucus production
They inhibit the influx of basophils and lymphocytes into the airways
Whats the DOC used in treatment of mild to moderate asthma for prophylaxis
Leukotriene Modulators
ADR of leukotriene Modulators
raise in the liver enzyme level
Inhibits phospholipase A2 enzyme
Glococortocoids
Zileuton
Leukotriene Synthesis Inhibitor
inhibits LOX enzyme
Montelukast
Zafirlukast
leukotriene receptor blockers
MOA of xanthines
Phosphodiesterase inhibitors – increase cyclic AMP – dephosphorylation - relaxation
Theophylline alone is an adenosin receptor antagonist
ADR of Xantines
causes alertness, tremors.
CVS effects- stimulates CVS, Increases heart rate, + ve chronotropic. (narrow ther. margin)
Weak diuretic effect ( Increases GFR and Reduces tubular reabsorption
xanthine with low therapeutic magin and dual MOA
THEOPHYLINE
atropium
M3 blockers
increase the mucociliary clearance
m3 blockers atropium
prevent release of inflammatory mediators
Mast Cell Stabilizers
Sodium cromoglicate
Nedocromil Sodium
Drug used in management os status asthmaticus
Adrenaline
Antitussives
used in dry non productive cough - Codein -bad cough
Expectorants
used only in the management productive cough
Expectorants MOA
increases tracheobronchial secretions or breaks the disulfide bonds
Expectorants drugs
Guaiphenesin
Bromhexine
Acetyl cysteine
Carbocysteine